Literature DB >> 3119512

Evidence for N-acetylmannosamine as an ocular receptor for P. aeruginosa adherence to scarified cornea.

L D Hazlett1, M M Moon, M Strejc, R S Berk.   

Abstract

This study provides evidence for an N-acetylmannosamine (manNac) receptor mediating in vivo bacterial adherence of P. aeruginosa to the scarified corneal epithelial surface. Bacteria, whether exposed to the inhibiting sugar or not, did not adhere immediately after inoculation, but required time in contact with the scarified corneal surface to adhere and adherence increased with time. Organisms were observed primarily adherent to the surface of epithelial cells lining the wound and were less frequently seen on areas of denuded stroma. Saturation of binding sites on the bacterial surface by manNac inhibited attachment of the organisms to newly exposed surface membrane receptors. In vivo protection studies showed excellent correlation with quantitative analysis of scanning electron micrographs, in that the number of adherent organisms at the corneal surface at 60 min following scarification and bacterial inoculation was decreased significantly by prior treatment of the bacteria with manNac when compared with PBS or the other monosaccharides. These data were confirmed by quantitative bacterial culture of excised corneas which had been similarly infected in vivo with PBS or manNac treated organisms.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3119512

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  42 in total

1.  Substance P affects growth factors in Pseudomonas aeruginosa-infected mouse cornea.

Authors:  Megan E B Foldenauer; Sharon A McClellan; Ronald P Barrett; Yunfan Zhang; Linda D Hazlett
Journal:  Cornea       Date:  2012-10       Impact factor: 2.651

2.  Binding of Pseudomonas aeruginosa to neutral glycosphingolipids of rabbit corneal epithelium.

Authors:  N Panjwani; T S Zaidi; J E Gigstad; F B Jungalwala; M Barza; J Baum
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

3.  Characterization of Pseudomonas aeruginosa adherence to mouse corneas in organ culture.

Authors:  A Singh; L D Hazlett; R S Berk
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

4.  Castroviejo Lecture 2009: 40 years in search of the perfect contact lens.

Authors:  H Dwight Cavanagh; Danielle M Robertson; W Matthew Petroll; James V Jester
Journal:  Cornea       Date:  2010-10       Impact factor: 2.651

5.  Mammalian target of rapamycin regulates IL-10 and resistance to Pseudomonas aeruginosa corneal infection.

Authors:  Megan E B Foldenauer; Sharon A McClellan; Elizabeth A Berger; Linda D Hazlett
Journal:  J Immunol       Date:  2013-04-26       Impact factor: 5.422

6.  Characterization of the Pseudomonas aeruginosa pilus adhesin: confirmation that the pilin structural protein subunit contains a human epithelial cell-binding domain.

Authors:  R T Irvin; P Doig; K K Lee; P A Sastry; W Paranchych; T Todd; R S Hodges
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

7.  Efficacy of VIP as Treatment for Bacteria-Induced Keratitis Against Multiple Pseudomonas aeruginosa Strains.

Authors:  Thomas W Carion; Cody R McWhirter; Daiyajot K Grewal; Elizabeth A Berger
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-10       Impact factor: 4.799

8.  Role of the Fas pathway in Pseudomonas aeruginosa keratitis.

Authors:  Zimei Zhou; Minhao Wu; Ronald P Barrett; Sharon A McClellan; Yunfan Zhang; Linda D Hazlett
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-17       Impact factor: 4.799

9.  Rat silicone hydrogel contact lens model: effects of high- versus low-Dk lens wear.

Authors:  Yunfan Zhang; Manal M Gabriel; Mary F Mowrey-McKee; Ronald P Barrett; Sharon McClellan; Linda D Hazlett
Journal:  Eye Contact Lens       Date:  2008-11       Impact factor: 2.018

10.  The role of VIP in cornea.

Authors:  Xiaoyu Jiang; Sharon A McClellan; Ronald P Barrett; Yunfan Zhang; Megan E Foldenauer; Linda D Hazlett
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-11-07       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.